Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amarin Corporation plc

     Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amarin
                               Corporation plc

PR Newswire

NEW YORK, Oct. 14, 2013

NEW YORK, Oct. 14, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein,
Gewirtz & Grossman, LLC is investigating potential claims on behalf of
purchasers of the securities of Amarin Corporation plc ("Amarin" or the
"Company") (NasdaqGM: AMRN). Such investors are advised to contact Peretz
Bronstein or his investor Relation's coordinator Eitan Kimelman at
info@bgandg.com or 212-697-6484.

The investigation concerns whether Amarin and certain of its officers and/or
directors have violated Sections 10(b) and 20(a) of the Securities Exchange
Act of 1934. On October 11, 2013, shares of Amarin fell $1.28 or 20.09% to
close at $5.09 after the FDA released its briefing documents for the October
16, 2013 advisory committee review of Amarin's application seeking expanded
approval for the use of its fish oil-based drug, Vascepa, in the treatment of
adult patients with high triglycerideswithmixeddyslipidemia. The FDA
briefing documents raised questions about the mineral oil placebo potentially
negatively impacting the control group data and consequentially overstating
Vascepa's effectiveness.

If you are aware of any facts relating to this investigation, or purchased
shares of Amarin, you can assist this investigation by contacting Peretz
Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein,
Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those
who inquire by e-mail are encouraged to include their mailing address, email
and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our
primary expertise is the aggressive pursuit of litigation claims on behalf of
our clients. In addition to representing institutions and other investor
plaintiffs in class action security litigation, the firm's expertise includes
general corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not guarantee similar
outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com

SOURCE Bronstein, Gewirtz & Grossman, LLC

Website: http://www.bgandg.com
 
Press spacebar to pause and continue. Press esc to stop.